---
title: "Altamira Therapeutics Ltd. (CYTOF.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/CYTOF.US.md"
symbol: "CYTOF.US"
name: "Altamira Therapeutics Ltd."
industry: "Pharmaceuticals"
---

# Altamira Therapeutics Ltd. (CYTOF.US)

| Item | Detail |
|------|--------|
| Industry | Pharmaceuticals |
| Location | US Market |
| Website | [altamiratherapeutics.com](https://altamiratherapeutics.com) |

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -0.11 | 66/257 | - | - | - |
| PB | 0.15 | 7/257 | 0.13 | 0.09 | 0.07 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2024-12-27T05:00:00.000Z

Total Analysts: **1**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 0 | 0% |
| Overweight | 0 | 0% |
| Hold | 0 | 0% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 0.10 |

## References

- [Company Overview](https://longbridge.com/en/quote/CYTOF.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/CYTOF.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/CYTOF.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.